Market Access News | pharmaphorum

News

A new formulation of Novartis' antimalarial Coartem has become the first medicine to be approved for use in very young children.

News

Medical groups have sued HHS Secretary Robert F Kennedy Jr for removing healthy children and pregnant women from COVID-19 shot recommendations.

News

KalVista has brought the first oral, on-demand treatment for hereditary angioedema attacks to the US market.

News

LifeArc and Genetics Alliance UK have issued a call to the government to remove obstacles impeding R&D into rare diseases.

News

Trump's One Big Beautiful Bill Act is signed into law, and commentators are gauging its impact on healthcare insurance coverage.

News

J&J is hoping the AMPLITUDE study results will make Akeega the first drug in the PARP inhibitor class for castration-sensitive prostate cancer.